Amended Complaint Filed Over Ditropan

Law360, New York (May 30, 2007, 12:00 AM EDT) -- Less than three weeks after a federal judge threw out an antitrust class action complaint against the maker of the bladder drug Ditropan XL, the plaintiffs filed an amended complaint Tuesday in a San Francisco federal court.

Both complaints accuse the makers and distributors of Ditropan XL of illegally trying to keep generic versions off the market by suing and entering into anti-competitive agreements with potential competitors.

But the new complaint contains some changes, including a second defendant, Ortho-McNeil Pharmaceuticals Inc.—the company that distributes Ditropan XL...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.